ID: ALA4102903

Max Phase: Preclinical

Molecular Formula: C12H9N3

Molecular Weight: 195.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1cncc(-c2c[nH]c3cnccc23)c1

Standard InChI:  InChI=1S/C12H9N3/c1-2-9(6-13-4-1)11-7-15-12-8-14-5-3-10(11)12/h1-8,15H

Standard InChI Key:  HLTAEMCUWJSTRY-UHFFFAOYSA-N

Associated Targets(Human)

Nuclear factor of activated T-cells cytoplasmic 1 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycogen synthase kinase-3 beta 11785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dual-specificity tyrosine-phosphorylation regulated kinase 1A 6484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.22Molecular Weight (Monoisotopic): 195.0796AlogP: 2.62#Rotatable Bonds: 1
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.86CX Basic pKa: 5.32CX LogP: 1.28CX LogD: 1.28
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.65Np Likeness Score: -0.45

References

1. Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM..  (2017)  Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.,  27  (11): [PMID:28408219] [10.1016/j.bmcl.2017.03.037]

Source